IJU Case Reports (Mar 2022)

Cytoreductive robot‐assisted prostatectomy for systemic prostate rhabdomyosarcoma presenting as urinary retention

  • Takahiro Kirisawa,
  • Arinobu Fukunaga,
  • Hajime Takamori,
  • Aiko Maejima,
  • Yasuo Shinoda,
  • Motokiyo Komiyama,
  • Hiroyuki Fujimoto,
  • Kan Yonemori,
  • Akihiko Yoshida,
  • Yoshiyuki Matsui

DOI
https://doi.org/10.1002/iju5.12411
Journal volume & issue
Vol. 5, no. 2
pp. 122 – 125

Abstract

Read online

Introduction In adults, rhabdomyosarcoma of the prostate is extremely rare and has an unfavorable prognosis. These patients frequently experience urinary obstruction, and cysto‐prostatectomy is a mainstay treatment for localized disease. In contrast, treatment strategies for the primary site for metastatic disease remain controversial. To our knowledge, robot‐assisted surgery for the primary tumor has not been reported. Case presentation A 26‐year‐old man complained of dysuria. Magnetic resonance imaging showed enlarged prostate and computed tomography revealed a pulmonary metastasis. Transurethral resection of the prostate led to the diagnosis of rhabdomyosarcoma. After chemotherapy, robot‐assisted prostatectomy was performed to relieve obstructive urinary symptoms. Although disease progression in the metastatic site was observed after the surgery, urinary obstruction did not occur and quality of life was well maintained. Conclusion Robot‐assisted prostatectomy may be beneficial both for local disease control and palliation of voiding impairment among selected patients with systemic rhabdomyosarcoma of the prostate.

Keywords